Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of PSME4 mRNA | affects expression | 21346803
|
C016601 |
4-hydroxytamoxifen |
4-hydroxytamoxifen results in decreased expression of PSME4 mRNA | decreases expression | 16514628
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of PSME4 mRNA | affects expression | 16483693
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of PSME4 mRNA | increases expression | 20106945
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of PSME4 mRNA | decreases expression | 18042831
|
D004958 |
Estradiol |
Estradiol results in increased expression of PSME4 mRNA | increases expression | 16514628
|
C070081 |
fulvestrant |
fulvestrant results in decreased expression of PSME4 mRNA | decreases expression | 16514628
|
C041786 |
palm oil |
palm oil results in decreased expression of PSME4 mRNA | decreases expression | 18042831
|
D020849 |
Raloxifene |
Raloxifene results in decreased expression of PSME4 mRNA | decreases expression | 16514628
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of PSME4 mRNA | affects expression | 17440010
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of PSME4 mRNA | increases expression | 19465110
|
D014747 |
Vinblastine |
PSME4 protein affects the susceptibility to Vinblastine | affects response to substance | 16217747
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.00 | 14514962 11752688 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.71 | 18287403 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.12 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.53 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.72 | 17308373 17451421 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.56 | 15800139 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.05 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
4.03 | 15238619 |
MESH:D001284 |
Atrophy |
|
fulvestrant |
4.97 | 11514358 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.15 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.96 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.83 | 15746008 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.61 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.38 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.38 | 18497071 17289903 16675129 17261762 12948864 19861407 14630087 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
fulvestrant |
2.38 | 18984771 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
2.38 | 17261762 16912660 17952589 15758505 15775269 17893378 17242785 15572757 16837676 17049068 17595753 17440819 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.38 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.62 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.89 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
3.01 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
3.01 | 16924424 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Vinblastine |
3.83 | 1485588 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
4.17 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.42 | 18850075 16120746 18670907 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.52 | 15775269 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
11.58 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.58 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
11.58 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.26 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.00 | 19486331 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.14 | 8697196 12621046 15340226 15668235 16354765 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.76 | 15800139 |
MESH:D015179 |
Colorectal Neoplasms |
|
Vinblastine |
2.76 | 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 20055451 15322242 10048152 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.16 | 18551238 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.26 | 17474826 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.69 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
9.34 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
9.34 | 17451421 17308373 15920148 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
3.79 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.79 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.84 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.53 | 18367378 |
MESH:D004487 |
Edema |
|
Raloxifene |
7.22 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.22 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.08 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
4.12 | 15845917 |
MESH:D016889 |
Endometrial Neoplasms |
|
4-hydroxytamoxifen |
8.02 | 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
8.02 | 11473722 18566989 19148513 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.12 | 10568697 9294722 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.09 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
13.83 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
13.83 | 18296743 19004024 17967931 19551842 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
13.83 | 17473493 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.59 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
15.56 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
15.56 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
15.56 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.37 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.77 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.38 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.61 | 11110106 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.58 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.44 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.03 | 15340226 16120746 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.21 | 15709030 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
5.92 | 17440010 |
MESH:D006689 |
Hodgkin Disease |
|
Vinblastine |
4.12 | 18180244 18501091 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.93 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.22 | 16354765 18606429 15340226 16959395 8697196 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.70 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.73 | 21332399 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.80 | 10903974 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
8.80 | 17577099 15787275 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.80 | 18670907 18850075 |
MESH:D007248 |
Infertility, Male |
|
fulvestrant |
3.82 | 11514358 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
5.09 | 20412841 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.09 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
7.60 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.60 | 16393666 16627594 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.44 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.62 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.14 | 8314463 18776723 10903974 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
6.14 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
12.91 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
12.91 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
12.91 | 15610895 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.61 | 16973256 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
2.93 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
2.29 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.29 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
4.49 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.49 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
5.95 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.95 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
1.24 | 19555203 11884234 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
2.62 | 11807958 16891317 17203775 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.66 | 19453300 |
MESH:D008545 |
Melanoma |
|
Vinblastine |
2.92 | 15577320 18176117 16248763 18505091 17761969 16432458 15577323 16809738 18332650 12374674 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.96 | 16801185 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.73 | 15863610 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.51 | 16497877 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.11 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.36 | 16810080 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.73 | 16343187 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.01 | 18551238 7678174 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.89 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.62 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.38 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.89 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.89 | 14600291 |
MESH:D009503 |
Neutropenia |
|
Vinblastine |
4.69 | 17378895 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
2.31 | 18674790 18457598 19632207 11836018 20518802 16723640 17217161 20132043 21332399 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.53 | 16049721 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.46 | 15775268 19059307 17882678 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.34 | 15758505 15579764 17823083 17893378 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.25 | 19401270 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.42 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.69 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.32 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.34 | 11222880 11399792 11896295 11118676 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.99 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.31 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
3.31 | 16220300 15731164 16536755 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.26 | 16882103 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.73 | 15770314 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.96 | 18990726 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.61 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.09 | 16192470 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.91 | 16837676 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.08 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
14.30 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
14.30 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.34 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
5.34 | 17572228 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.47 | 10091137 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.16 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Vinblastine |
5.18 | 15577323 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.77 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.38 | 16837676 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.73 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.42 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.83 | 16723640 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.62 | 17120751 |